Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics (Q40283818)

19 September 2017

title

Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics (English)

1 reference

19 September 2017

0 references

0 references

1 reference

Maria Preobrazhenskaya

10

1 reference

19 September 2017

Els Keyaerts

2

0 references

Marc Van Ranst

Marc Van Ranst

6

0 references

Erik De Clercq

Erik De Clercq

5

0 references

Jan Balzarini

1

Jan Balzarini

1 reference

19 September 2017

3

Leen Vijgen

1 reference

19 September 2017

4

Herman Egberink

1 reference

19 September 2017

Svetlana S Printsevskaya

7

Svetlana S Printsevskaya

1 reference

19 September 2017

8

Eugenia N Olsufyeva

1 reference

19 September 2017

Svetlana E. Solovieva

9

Svetlana E Solovieva

1 reference

19 September 2017

language of work or name

1 reference

6 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

72

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

20-33

1 reference

Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships

19 September 2017

cites work

1 reference

12 December 2020

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VII. Preparation and NMR characteristics of the aglycone of teicoplanin

1 reference

12 December 2020

A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity

1 reference

12 December 2020

Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal

1 reference

12 December 2020

Thioureas and isothiouronium salts of the aglycone of teicoplanin. I. Synthesis and biological activity

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

N15-alkyl and N15,N15-dialkyl derivatives of teicoplanin antibiotics

1 reference

12 December 2020

Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines

1 reference

12 December 2020

A modification of the N-terminal amino acid in the eremomycin aglycone

1 reference

12 December 2020

Carboxamides and hydrazide of glycopeptide antibiotic eremomycin. Synthesis and antibacterial activity

1 reference

12 December 2020

Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics

1 reference

12 December 2020

Structure-activity relationships in the series of eremomycin carboxamides.

1 reference

12 December 2020

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Vancomycin resistance: decoding the molecular logic

1 reference

12 December 2020

Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria

1 reference

12 December 2020

SARS-Associated Coronavirus

1 reference

12 December 2020

Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.

1 reference

12 December 2020

Synthesis and antibacterial activity of derivatives of the glycopeptide antibiotic A-40926 and its aglycone.

1 reference

12 December 2020

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

1 reference

12 December 2020

Mono and double modified teicoplanin aglycon derivatives on the amino acid no. 7; structure-activity relationship

1 reference

12 December 2020

Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics

1 reference

12 December 2020

Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I

1 reference

12 December 2020

Synthesis and biological activity of some esters of the N-acetylglucosaminyl aglycone and of the aglycone of teicoplanin

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Synthesis of hydrophobic N'-mono and N',N"-double alkylated eremomycins inhibiting the transglycosylation stage of bacterial cell wall biosynthesis.

1 reference

12 December 2020

Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin

1 reference

12 December 2020

[The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin].

1 reference

12 December 2020

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

12 December 2020

Chemical modification of antibiotic eremomycin at the asparagine side chain.

1 reference

12 December 2020

Synthesis and antibacterial evaluation of N-alkyl vancomycins

1 reference

12 December 2020

Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

1 reference

12 December 2020

Structure-activity relationships of vancomycin-type glycopeptide antibiotics

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VIII. Opening of the polypeptide chain of teicoplanin aglycone under hydrolytic conditions

1 reference

12 December 2020

Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture

1 reference

12 December 2020

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

1 reference

12 December 2020

The Genome sequence of the SARS-associated coronavirus

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2006.03.005

Identifiers

DOI

1 reference

19 September 2017

1 reference